Deprecated: implode(): Passing glue string after array is deprecated. Swap the parameters in /home4/zagdimco/public_html/website1/wp-content/themes/pennews/inc/media.php on line 245

Deprecated: implode(): Passing glue string after array is deprecated. Swap the parameters in /home4/zagdimco/public_html/website1/wp-content/themes/pennews/inc/media.php on line 245

Deprecated: implode(): Passing glue string after array is deprecated. Swap the parameters in /home4/zagdimco/public_html/website1/wp-content/themes/pennews/inc/media.php on line 245
People moves - Page 31 of 37 - BIO Archive

People moves

Liz Gyekye

Novozymes announce appointment of new EVP and CFO

Novozymes has announced that it will appoint Lars Green as its new EVP and CFO. He will start in the role as of 1 September, with responsibility for finance, IT, legal and investor relations.
Green has worked for Novo Nordisk A/S for 27 years where, most recently, he has headed up Business Services and Compliance, and – as EVP – been part of Novo Nordisk’s Executive Management team. Before assuming his current position, he was head of finance & operations for Novo Nordisk in North America. He has been a member of Novozymes’ Board of Directors since 2014 and chairman of the Audit Committee.

In a joint statement about the appointment, Jør gen Buhl Rasmussen, Chairman of the Board of Directors, and CEO Peder Holk Nielsen, said: “We’re very pleased to announce that Lars has accepted the role as EVP and CFO of Novozymes. We’re convinced that Lars is a good match for Novozymes. His ability to set the CFO agenda and engage with the organisation will help us deliver on our strategy ‘Better business with biology.’

“As a member of the Board of Directors since 2014, Lars has gained a profound knowledge of Novozymes’ business and meets the requirements for the broad array of tasks and responsibilities the CFO position encompasses. Lars brings extensive experience and a good cultural match to Novozymes from his current position as EVP Business Services and Compliance and a member of Executive Management of Novo Nordisk.”

Speaking about his appointment, Green: “I’m very excited to join Novozymes and look forward to developing our strategic plans and delivering on the targets set out in relation to the strategy update together with the rest of the Executive Leadership Team and Novozymes’ employees.”

Novozymes said that following his appointment as EVP and CFO, Lars Green has resigned from the Board of Directors with immediate effect, including as chairman of the Audit Committee. Novozymes’ Board of Directors has elected Agnete Raaschou-Nielsen as the new chair of the Audit Committee with immediate effect.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More